THE DEFINITIVE GUIDE TO AGO TUMOR

Molecular typing is based on molecular genetic tests and is not nevertheless routinely available. Molecular subtypes and immunohistochemical surrogate markers with the tumors (HR, HER2, triple damaging) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-67 can be helpful, but a f